CBIO - Catalyst Biosciences

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

CBIO - Catalyst Biosciences

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Tue 18'th Sep 2018

PERIOD 2018-06-19 - 2018-09-18
CHANGE 0.96%
PRICE $9.44





Request Prediction

Catalyst Biosciences Stock Analysis

Technical stock analysis for Tue 18'th Sep 2018

Sell candidate since 2018-09-04 Loss -11.78%
Shorts 6.10% ( 2018-08-31 )
Cash 27.5 mill
Loans n/a
Beta 1.96
ROA -25.75

Catalyst Biosciences gained 0.96% in the last trading day, rising from $9.35 to $9.44 The price has fallen in 7 of the last 10 days and is down by -11.78% for this period. Volume fell in the last day by -85 714 shares, and in total, 200 341 shares bought and sold for approximately $1.89 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.


Catalyst Biosciences lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.78% during the next 3 months and, with 90% probability hold a price between $7.62 and $10.00 at the end of this period.

Click here for today's Top 5 Trending Companies


A buy signal was issued from a pivot bottom point on Monday September 17, 2018, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Catalyst Biosciences holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $9.65 and $10.27. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 18 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

Catalyst Biosciences finds support from accumulated volume at $9.39.

Support: $9.39 Price: $9.44 Resistance: $10.46


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.54 between high and low, or 5.97%. For the last week, the stock has had a daily average volatility of 5.09%.

Catalyst Biosciences is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


Catalyst Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Sell Candidate

Click for Top 5 Sell Candidates
CBIO $9.44 $0.09(0.96%)
CBIO is up $0.09 today, but where's it headed in October?
Zacks Investment Research is releasing its prediction for CBIO based on the 1-3 month system that more than doubles the S&P 500.

Click here – the CBIO analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with